Diacyglycerol Signaling in Breast Cancer
- Mechanisms of DAG signaling dysregulation in triple-negative breast cancer (TNBC)
- Association of DAG-regulated PKC isozymes with epithelial-to-mesenchymal transition (EMT) and invasiveness in TNBC
- Control of EMT transcription factor expression by PKC.
- Influence of aberrant DAG signaling in immune checkpoint protein expression and the tumor immune landscape in breast cancer.